Hengrui Medicine (01276) has cumulatively repurchased 1,636,200 A-shares as of the end of October.

Zhitong Finance APP News, Hengrui Pharmaceuticals (01276) issued an announcement that, as of October 31, 2026, the company's current share repurchase plan had cumulatively repurchased 1.6362 million A-shares through the Shanghai Stock Exchange trading system by way of centralized bidding transactions. The repurchased shares accounted for 0.025% of the company's total share capital. The highest purchase price was RMB 46.33 per share, and the lowest price was RMB 43.10 per share. The total amount paid was RMB 73.8849 million (excluding transaction fees).